{"schemaVersion":"wpf-profile-export-v1","exportedAt":"2026-09-18T15:17:30.882Z","profile":{"slug":"leuprolide","name":"Leuprolide","aliases":[],"category":"GnRH agonist"},"synthesis":{"mechanism":"Leuprolide is a synthetic nonapeptide agonist of the gonadotropin-releasing hormone receptor. Initial continuous exposure can transiently increase luteinizing hormone, follicle-stimulating hormone, and gonadal steroid concentrations; sustained depot exposure then desensitizes pituitary GnRH signaling and suppresses gonadal steroid production. This biphasic action supports product-specific uses in prostate cancer, central precocious puberty, endometriosis, and uterine fibroids, while stimulation-test and assisted-reproduction contexts use different timing and objectives.","evidence":"The governed 25-source corpus spans foundational pharmacokinetics, prostate-cancer androgen deprivation and comparative antagonist trials, cardiovascular outcomes, central-precocious-puberty monitoring and formulation studies, endometriosis and add-back therapy, uterine-fibroid and perioperative trials, assisted reproduction, large prospective practice data, and systematic reviews. PubMed titles, authorship, DOI/PMID, publication metadata, molecule relevance, active source status, and duplication were verified. Comparator trials are labeled as such and do not turn evidence about another drug into evidence for unstudied leuprolide effects.","safety":"The initial hormonal flare can temporarily worsen disease manifestations in susceptible patients. Longer suppression can affect bone density, vasomotor symptoms, mood, sexual function, fertility, body composition, glucose and cardiovascular risk; pediatric monitoring and pregnancy exclusions require indication-specific attention. Depot products and intervals are not automatically interchangeable. Trial eras, open-label designs, surrogate endpoints, background therapies, and sponsor involvement limit some comparisons. Current labeling and specialist guidance—not this profile—control selection, precautions, monitoring, and use.","observationalBoundary":"Leuprolide reliably produces pharmacologic suppression after the initial agonist phase when an appropriate depot regimen is used, but clinically meaningful outcomes depend on disease, formulation, interval, duration, comparator, and co-therapy. Prostate-cancer evidence includes oncologic control, testosterone recovery, and cardiovascular comparisons; pediatric evidence focuses on pubertal suppression and growth outcomes; gynecologic evidence addresses pain, bleeding, fibroid volume, surgery, bone loss, and add-back strategies. These lanes remain separate and no dosing or cross-indication inference is made.","openQuestions":"Which patients benefit most from agonist rather than antagonist androgen deprivation in contemporary prostate-cancer care? How should baseline cardiovascular risk influence selection? What durations and add-back regimens best protect bone and quality of life in gynecologic indications? Which pediatric monitoring thresholds best predict adequate suppression and adult-height outcomes? How equivalent are current depot formulations in real-world exposure and adherence? What long-term metabolic, neuropsychiatric, fertility, and skeletal effects remain undercharacterized across populations?"},"completion":{"version":"wpf-profile-v1.0","complete":false,"checks":[{"key":"overview","passed":true,"actual":576,"required":100,"severity":"blocking"},{"key":"evidence_summary","passed":true,"actual":646,"required":100,"severity":"blocking"},{"key":"safety_summary","passed":true,"actual":633,"required":100,"severity":"blocking"},{"key":"archive_boundary","passed":true,"actual":613,"required":75,"severity":"blocking"},{"key":"open_questions","passed":true,"actual":591,"required":75,"severity":"blocking"},{"key":"verified_sources","passed":true,"actual":25,"required":25,"severity":"blocking"},{"key":"reviewed_sources","passed":false,"actual":0,"required":1,"severity":"blocking"},{"key":"chemistry","passed":true,"actual":true,"required":true,"severity":"blocking"},{"key":"regulatory_context","passed":true,"actual":2,"required":2,"severity":"blocking"},{"key":"claims","passed":false,"actual":0,"required":1,"severity":"blocking"},{"key":"claim_traceability","passed":true,"actual":0,"required":0,"severity":"blocking"},{"key":"regulatory_freshness","passed":true,"actual":0,"required":0,"severity":"warning"}],"failures":["reviewed_sources","claims"]},"chemistry":{"id":"d46e4a1c3c885f33cfcefa14bcfc0b50","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","molecularFormula":"C59H84N16O12","molecularWeight":1209.4,"aminoAcidSequence":"pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt","smiles":"CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6","inchi":"InChI=1S/C59H84N16O12/c1-6-63-57(86)48-14-10-22-75(48)58(87)41(13-9-21-64-59(60)61)68-51(80)42(23-32(2)3)69-52(81)43(24-33(4)5)70-53(82)44(25-34-15-17-37(77)18-16-34)71-56(85)47(30-76)74-54(83)45(26-35-28-65-39-12-8-7-11-38(35)39)72-55(84)46(27-36-29-62-31-66-36)73-50(79)40-19-20-49(78)67-40/h7-8,11-12,15-18,28-29,31-33,40-48,65,76-77H,6,9-10,13-14,19-27,30H2,1-5H3,(H,62,66)(H,63,86)(H,67,78)(H,68,80)(H,69,81)(H,70,82)(H,71,85)(H,72,84)(H,73,79)(H,74,83)(H4,60,61,64)/t40-,41-,42-,43+,44-,45-,46-,47-,48-/m0/s1","inchikey":"GFIJNRVAKGFPGQ-LIJARHBVSA-N","structureImageUrl":"https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/657181/PNG","createdAt":"2026-09-09T22:35:39.247Z","updatedAt":"2026-09-09T22:35:39.247Z"},"evidence":[{"id":"53c78ca93cfe438f38b93bf9dcc7264f","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"The Effect of Leuprolide Acetate 11.25 mg 3-Month Formulation in Children with Central Precocious Puberty: A Systematic Review and Meta-analysis.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/40498278/","evidenceTier":"observational","summary":"Compared to the well-established leuprolide acetate (LA) 1-month formulations, the LA 11.25 mg 3-month formulation could reduce the frequency of injections and potentially improve treatment adherence in children with central precocious puberty (CPP).","authors":"Linqi Han, Chunjuan Zhai, La Da, Yan Sun","publishingOrg":"Advances in therapy","publicationYear":2025,"doi":"10.1007/s12325-025-03222-7","pubmedId":"40498278","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"systematic_review_or_meta_analysis","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1007/s12325-025-03222-7","sourceIdentityId":"74aff46b4530a8c48cb9c486c402923c","sourceStatus":"active","sourceContentHash":"e4d9ce4b30378a42dbae6753c86da57672bc5240d206c2cdd1e580ed5f2cf9f9","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:40498278","evidenceLane":"meta_analysis","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"systematic review and meta-analysis","sourceStrength":{"grade":"A","score":88,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":85,"replication":70,"studyDesign":88,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1007/s12325-025-03222-7","locator":"https://pubmed.ncbi.nlm.nih.gov/40498278/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"e4d9ce4b30378a42dbae6753c86da57672bc5240d206c2cdd1e580ed5f2cf9f9","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"40498278","rawPayloadReference":"pubmed:40498278"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"systematic_review_or_meta_analysis","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"ec301cb3067d75a668502b095e6ce29e","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"Effectiveness of leuprolide acetate administered monthly compared to three-monthly in the treatment of central precocious puberty: evaluation at the end of treatment.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/38737553/","evidenceTier":"observational","summary":"Gonadotropin-releasing hormone (GnRH) analogs are the standard treatment for central precocious puberty (CPP).","authors":"Thanaporn Thaneetrakool, Suphab Aroonparkmongkol, Nattakarn Numsriskulrat, Vichit Supornsilchai, Suttipong Wacharasindhu, Khomsak Srilanchakon","publishingOrg":"Frontiers in endocrinology","publicationYear":2024,"doi":"10.3389/fendo.2024.1390674","pubmedId":"38737553","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.3389/fendo.2024.1390674","sourceIdentityId":"f4cc34693a86b1a5c33856d2fa898cf1","sourceStatus":"active","sourceContentHash":"94bffbcc4afacd01055008519527ff4cbc94116eae67e307e3265d63a276eb38","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:38737553","evidenceLane":"human_observational","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"observational, comparative, monitoring, or contextual human study","sourceStrength":{"grade":"B","score":75,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":85,"replication":70,"studyDesign":75,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.3389/fendo.2024.1390674","locator":"https://pubmed.ncbi.nlm.nih.gov/38737553/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"94bffbcc4afacd01055008519527ff4cbc94116eae67e307e3265d63a276eb38","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"38737553","rawPayloadReference":"pubmed:38737553"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"8ed568ea7f92651e59b24d280070b105","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/38143206/","evidenceTier":"phase_3","summary":"In the HERO study, relugolix demonstrated sustained testosterone suppression superior to that of leuprolide acetate (97% vs 89%; difference 7.9% [95% confidence interval, 4.1-12%; p < 0.001]).","authors":"Ronald Tutrone, Fred Saad, Daniel J George, Bertrand Tombal, James L Bailen, Michael S Cookson, Daniel R Saltzstein, Sarah Hanson, Bruce Brown, Sophia Lu, Mark Fallick, Neal D Shore","publishingOrg":"European urology oncology","publicationYear":2024,"doi":"10.1016/j.euo.2023.11.024","pubmedId":"38143206","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1016/j.euo.2023.11.024","sourceIdentityId":"ce99165e304aa5a8c4a81a74886608ab","sourceStatus":"active","sourceContentHash":"5a510cf4d3be9844577a7f13ec7abddc87d1bbd9072fa791f1c4d435f1995e8e","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:38143206","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"A","score":91,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":85,"replication":70,"studyDesign":91,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1016/j.euo.2023.11.024","locator":"https://pubmed.ncbi.nlm.nih.gov/38143206/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"5a510cf4d3be9844577a7f13ec7abddc87d1bbd9072fa791f1c4d435f1995e8e","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"38143206","rawPayloadReference":"pubmed:38143206"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"ee4b0f2316f1dfa807dd90778ef89d26","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/37851874/","evidenceTier":"phase_3","summary":"Patients with prostate cancer who have high-risk biochemical recurrence have an increased risk of progression.","authors":"Stephen J Freedland, Murilo de Almeida Luz, Ugo De Giorgi, Martin Gleave, Geoffrey T Gotto, Christopher M Pieczonka, Gabriel P Haas, Choung-Soo Kim, Miguel Ramirez-Backhaus, Antti Rannikko, Jamal Tarazi, Swetha Sridharan","publishingOrg":"The New England journal of medicine","publicationYear":2023,"doi":"10.1056/nejmoa2303974","pubmedId":"37851874","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1056/nejmoa2303974","sourceIdentityId":"4726370767dce04218184685a71970da","sourceStatus":"active","sourceContentHash":"a00982f279d2c891f8e8f888e4d96080c8cd535bbe1223bfeb33b359c634eabe","sourceVersion":1,"retrievedAt":"2026-09-10T09:02:33.021Z","retrievalProvider":"pubmed","retrievalPayloadRef":"pubmed:37851874","evidenceLane":null,"extractionPayload":null,"provenancePayload":{"locator":"https://pubmed.ncbi.nlm.nih.gov/37851874/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-10T09:02:33.021Z","rawPayloadHash":"a00982f279d2c891f8e8f888e4d96080c8cd535bbe1223bfeb33b359c634eabe","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"37851874","rawPayloadReference":"pubmed:37851874"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":false,"required":true,"reasonCodes":["extraction_not_grounded_or_verified"]},{"id":"G5","passed":false,"required":true,"reasonCodes":["evidence_lane_unresolved"]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"quarantine","reasonCodes":["extraction_not_grounded_or_verified","evidence_lane_unresolved"],"catastrophic":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","roleDemotedFromPromotion":[],"admitsExactPublishedEvidence":true},"engineState":"quarantined","engineRunId":"be21bd35-91c5-43ed-8852-6e31f85ded4c","createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-10T09:02:50.393Z"},{"id":"94a143995c265f0ea06aee82295cf172","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/34459214/","evidenceTier":"phase_1_2","summary":"The relative cardiovascular safety of gonadotropin-releasing hormone (GnRH) antagonists compared with GnRH agonists in men with prostate cancer and known atherosclerotic cardiovascular disease remains controversial.","authors":"Renato D Lopes, Celestia S Higano, Susan F Slovin, Adam J Nelson, Robert Bigelow, Per S Sørensen, Chiara Melloni, Shaun G Goodman, Christopher P Evans, Jan Nilsson, Deepak L Bhatt, Noel W Clarke","publishingOrg":"Circulation","publicationYear":2021,"doi":"10.1161/circulationaha.121.056810","pubmedId":"34459214","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1161/circulationaha.121.056810","sourceIdentityId":"132a7081a42b6d88d8eb7d953cb89f14","sourceStatus":"active","sourceContentHash":"1f426801916ab926403a11fac5d24a1b3dfd1f8a204633c6879c6b79e744207c","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:34459214","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"B","score":80,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":85,"replication":70,"studyDesign":80,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1161/CIRCULATIONAHA.121.056810","locator":"https://pubmed.ncbi.nlm.nih.gov/34459214/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"1f426801916ab926403a11fac5d24a1b3dfd1f8a204633c6879c6b79e744207c","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"34459214","rawPayloadReference":"pubmed:34459214"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"93ea1539314d732fff268b1b1baf2fc2","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/32469183/","evidenceTier":"phase_3","summary":"Injectable luteinizing hormone-releasing hormone agonists (e.g., leuprolide) are the standard agents for achieving androgen deprivation for prostate cancer despite the initial testosterone surge and delay in therapeutic effect.","authors":"Neal D Shore, Fred Saad, Michael S Cookson, Daniel J George, Daniel R Saltzstein, Ronald Tutrone, Hideyuki Akaza, Alberto Bossi, David F van Veenhuyzen, Bryan Selby, Xiaolin Fan, Vicky Kang","publishingOrg":"The New England journal of medicine","publicationYear":2020,"doi":"10.1056/nejmoa2004325","pubmedId":"32469183","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1056/nejmoa2004325","sourceIdentityId":"ba562e8201c506c46c42cc5ff0ba3406","sourceStatus":"active","sourceContentHash":"0c6d2e15ce183a54f28c9cd3aa7799914658cb5048315045ee359f6d2af17472","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:32469183","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"A","score":91,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":70,"replication":70,"studyDesign":91,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1056/NEJMoa2004325","locator":"https://pubmed.ncbi.nlm.nih.gov/32469183/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"0c6d2e15ce183a54f28c9cd3aa7799914658cb5048315045ee359f6d2af17472","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"32469183","rawPayloadReference":"pubmed:32469183"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"d36ac15824b8f4c892a9b8cceaaf9153","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"A New Sustained-release, 3-Month Leuprolide Acetate Formulation Achieves and Maintains Castrate Concentrations of Testosterone in Patients With Prostate Cancer.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/30929678/","evidenceTier":"phase_3","summary":"This clinical trial investigated the effectiveness, pharmacokinetic properties, and safety profile of leuprolide acetate 22.5-mg depot, a new 3-month leuprolide depot formulation, as androgen deprivation therapy for patients with prostate cancer.","authors":"Neal D Shore, Sílvia Guerrero, Rosa Ma Sanahuja, Gemma Gambús, Antonio Parente","publishingOrg":"Clinical therapeutics","publicationYear":2019,"doi":"10.1016/j.clinthera.2019.01.004","pubmedId":"30929678","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1016/j.clinthera.2019.01.004","sourceIdentityId":"051cee14fdd4034a9d87f40421a8a2b4","sourceStatus":"active","sourceContentHash":"a4fe0d62e89f98b331d67fceb6bc7efbe6890a873c896bb68e3dfd9cf88d406a","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:30929678","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"A","score":91,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":85,"replication":70,"studyDesign":91,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1016/j.clinthera.2019.01.004","locator":"https://pubmed.ncbi.nlm.nih.gov/30929678/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"a4fe0d62e89f98b331d67fceb6bc7efbe6890a873c896bb68e3dfd9cf88d406a","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"30929678","rawPayloadReference":"pubmed:30929678"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"af1956d6e8e7f2b17b702bf6201284c9","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"Are all gonadotrophin-releasing hormone agonists equivalent for the treatment of prostate cancer? A systematic review.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/29438592/","evidenceTier":"observational","summary":"To review direct comparative studies of the gonadotrophin-releasing hormone (GnRH) agonists goserelin, triptorelin, and leuprorelin for the treatment of prostate cancer, and identify whether there are meaningful clinical differences between these agents.","authors":"Eva M Bolton, Thomas Lynch","publishingOrg":"BJU international","publicationYear":2018,"doi":"10.1111/bju.14168","pubmedId":"29438592","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"systematic_review_or_meta_analysis","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1111/bju.14168","sourceIdentityId":"6b4a0455439ed2493fdb21dd81242048","sourceStatus":"active","sourceContentHash":"fa31aa7ef0bb11b83bf764115583544e00b8b884a49d91a2d2994c5078999ccc","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:29438592","evidenceLane":"systematic_review","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"systematic review","sourceStrength":{"grade":"A","score":86,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":70,"replication":70,"studyDesign":86,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1111/bju.14168","locator":"https://pubmed.ncbi.nlm.nih.gov/29438592/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"fa31aa7ef0bb11b83bf764115583544e00b8b884a49d91a2d2994c5078999ccc","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"29438592","rawPayloadReference":"pubmed:29438592"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"systematic_review_or_meta_analysis","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"ecee854dba9f1a0ecf370814892a575e","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"FSH suppression and tumour control in patients with prostate cancer during androgen deprivation with a GnRH agonist or antagonist.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/30624128/","evidenceTier":"phase_3","summary":"Gonadotropin releasing hormone (GnRH) antagonists suppress follicle-stimulating hormone (FSH) to lower levels than GnRH agonists.","authors":"E David Crawford, B Tombal, T Keane, F Boccardo, K Miller, N Shore, J W Moul, J-E Damber, L Collette, B-E Persson","publishingOrg":"Scandinavian journal of urology","publicationYear":2018,"doi":"10.1080/21681805.2018.1522372","pubmedId":"30624128","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1080/21681805.2018.1522372","sourceIdentityId":"869f8d5b0503e8960394e7111fc14299","sourceStatus":"active","sourceContentHash":"ded733d1782d1cafb1fa26a04168ed6228c0dc866a663867a19abc73ae638983","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:30624128","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"A","score":91,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":70,"replication":70,"studyDesign":91,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1080/21681805.2018.1522372","locator":"https://pubmed.ncbi.nlm.nih.gov/30624128/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"ded733d1782d1cafb1fa26a04168ed6228c0dc866a663867a19abc73ae638983","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"30624128","rawPayloadReference":"pubmed:30624128"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"d6d5fb5e29afac855e5acdecc4cf5ff7","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"Monitoring treatment of central precocious puberty using basal luteinizing hormone levels and practical considerations for dosing with a 3-month leuprolide acetate formulation.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/27740929/","evidenceTier":"phase_3","summary":"Peak gonadotropin-releasing hormone or agonist (GnRHa) stimulated luteinizing hormone (LH) testing with leuprolide acetate (LA) is commonly used to document suppression during therapy for central precocious puberty (CPP).","authors":"Peter A Lee, Margaret Luce, Peter Bacher","publishingOrg":"Journal of pediatric endocrinology & metabolism : JPEM","publicationYear":2016,"doi":"10.1515/jpem-2016-0026","pubmedId":"27740929","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1515/jpem-2016-0026","sourceIdentityId":"12cdd1f1002b497089f440b38b8ab221","sourceStatus":"active","sourceContentHash":"80815f972647d1d16b5c77424ee2f8005b15684ca75b577a882b140de02b1194","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:27740929","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"A","score":91,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":85,"replication":70,"studyDesign":91,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1515/jpem-2016-0026","locator":"https://pubmed.ncbi.nlm.nih.gov/27740929/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"80815f972647d1d16b5c77424ee2f8005b15684ca75b577a882b140de02b1194","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"27740929","rawPayloadReference":"pubmed:27740929"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"ca9d3a637b4c64389ab571340f8ad015","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"Gonadotropin and Estradiol Levels after Leuprolide Stimulation Tests in Brazilian Girls with Precocious Puberty.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/26094907/","evidenceTier":"observational","summary":"To determine the best cutoff value on the leuprolide stimulation test for the diagnosis of central precocious puberty (CPP) in a Brazilian population.","authors":"Flavia R R Junqueira, Lucia A S Lara, Wellington P Martins, Rui A Ferriani, Ana Carolina J S Rosa-E-Silva, Marcos Felipe S de Sá, Rosana M Reis","publishingOrg":"Journal of pediatric and adolescent gynecology","publicationYear":2015,"doi":"10.1016/j.jpag.2014.09.006","pubmedId":"26094907","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1016/j.jpag.2014.09.006","sourceIdentityId":"8383663aab8ec26d09857225ac33d919","sourceStatus":"active","sourceContentHash":"1760797897ae9b0cd4a687b32780782b23467cb0a0a5f2ca114ce572f6dc38e1","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:26094907","evidenceLane":"human_observational","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"observational, comparative, monitoring, or contextual human study","sourceStrength":{"grade":"B","score":75,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":85,"replication":70,"studyDesign":75,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1016/j.jpag.2014.09.006","locator":"https://pubmed.ncbi.nlm.nih.gov/26094907/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"1760797897ae9b0cd4a687b32780782b23467cb0a0a5f2ca114ce572f6dc38e1","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"26094907","rawPayloadReference":"pubmed:26094907"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"6f05d3ed136fa0b5bd5cfb4285405770","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/22296076/","evidenceTier":"phase_3","summary":"The efficacy and side-effect profile of ulipristal acetate as compared with those of leuprolide acetate for the treatment of symptomatic uterine fibroids before surgery are unclear.","authors":"Jacques Donnez, Janusz Tomaszewski, Francisco Vázquez, Philippe Bouchard, Boguslav Lemieszczuk, Francesco Baró, Kazem Nouri, Luigi Selvaggi, Krzysztof Sodowski, Elke Bestel, Paul Terrill, Ian Osterloh","publishingOrg":"The New England journal of medicine","publicationYear":2012,"doi":"10.1056/nejmoa1103180","pubmedId":"22296076","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1056/nejmoa1103180","sourceIdentityId":"a6b4545a85615906149eb3ca06eea7c4","sourceStatus":"active","sourceContentHash":"581f11b4d4abc1d4ba8a8d0a9438d2083804e64a95e8be54ce23cefbd35955f7","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:22296076","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"A","score":91,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":85,"replication":70,"studyDesign":91,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1056/NEJMoa1103180","locator":"https://pubmed.ncbi.nlm.nih.gov/22296076/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"581f11b4d4abc1d4ba8a8d0a9438d2083804e64a95e8be54ce23cefbd35955f7","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"22296076","rawPayloadReference":"pubmed:22296076"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"660900ee19cc9b11a37a99416c619a8a","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"A 6-month depot formulation of leuprolide acetate is safe and effective in daily clinical practice: a non-interventional prospective study in 1273 patients.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/21801354/","evidenceTier":"phase_1_2","summary":"Testosterone stimulates growth in many prostate tumours.","authors":"Ulf W Tunn","publishingOrg":"BMC urology","publicationYear":2011,"doi":"10.1186/1471-2490-11-15","pubmedId":"21801354","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1186/1471-2490-11-15","sourceIdentityId":"e41dfc25d618eb45684b38102684a28d","sourceStatus":"active","sourceContentHash":"10efb68402209b199e101ff4bd32e54ea196a8b8c37c993eebaa4fc3d527d4c1","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:21801354","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"B","score":80,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":85,"replication":70,"studyDesign":80,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1186/1471-2490-11-15","locator":"https://pubmed.ncbi.nlm.nih.gov/21801354/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"10efb68402209b199e101ff4bd32e54ea196a8b8c37c993eebaa4fc3d527d4c1","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"21801354","rawPayloadReference":"pubmed:21801354"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"17fab6601732a4e36433a1a10dd44e1b","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/21300339/","evidenceTier":"phase_1_2","summary":"To compare the efficacy of leuprolide and continuous oral contraceptives in the treatment of endometriosis-associated pain.","authors":"David S Guzick, Li-Shan Huang, Betsy A Broadman, Maureen Nealon, Mark D Hornstein","publishingOrg":"Fertility and sterility","publicationYear":2011,"doi":"10.1016/j.fertnstert.2011.01.027","pubmedId":"21300339","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1016/j.fertnstert.2011.01.027","sourceIdentityId":"08c21c78f97a98fc1a6fac20633e9802","sourceStatus":"active","sourceContentHash":"2dfb5eedc6d80e9522dcdaf09951ab864db426b63392c2759fb53664b7526cba","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:21300339","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"B","score":80,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":85,"replication":70,"studyDesign":80,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1016/j.fertnstert.2011.01.027","locator":"https://pubmed.ncbi.nlm.nih.gov/21300339/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"2dfb5eedc6d80e9522dcdaf09951ab864db426b63392c2759fb53664b7526cba","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"21300339","rawPayloadReference":"pubmed:21300339"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"33f715ca9a7a033b1ed64a61e8137035","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"Utility of single luteinizing hormone determination 3 h after depot leuprolide in monitoring therapy of gonadotropin-dependent precocious puberty.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/19396631/","evidenceTier":"phase_1_2","summary":"To determine utility of luteinizing hormone (LH) estimation, post intramuscular (IM) depot leuprolide in comparison with subcutaneous leuprolide stimulation test.","authors":"Shrikrishna V Acharya, Raju A Gopal, Joe George, Tushar R Bandgar, Padma S Menon, Nalini S Shah","publishingOrg":"Pituitary","publicationYear":2009,"doi":"10.1007/s11102-009-0184-0","pubmedId":"19396631","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1007/s11102-009-0184-0","sourceIdentityId":"36cf4fce7e23432514d579cd8d6c67ca","sourceStatus":"active","sourceContentHash":"39a9dffaa8b58aca16870ced342e08d4073b2176f487db3b67324e9a80675548","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:19396631","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"B","score":80,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":85,"replication":70,"studyDesign":80,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1007/s11102-009-0184-0","locator":"https://pubmed.ncbi.nlm.nih.gov/19396631/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"39a9dffaa8b58aca16870ced342e08d4073b2176f487db3b67324e9a80675548","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"19396631","rawPayloadReference":"pubmed:19396631"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"88bd2e7554aea1e6d09a4c4d30392859","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/19035858/","evidenceTier":"phase_3","summary":"To evaluate the efficacy and safety of degarelix, a new gonadotrophin-releasing hormone (GnRH) antagonist (blocker), vs leuprolide for achieving and maintaining testosterone suppression in a 1-year phase III trial involving patients with prostate cancer.","authors":"Laurence Klotz, Laurent Boccon-Gibod, Neal D Shore, Cal Andreou, Bo-Eric Persson, Per Cantor, Jens-Kristian Jensen, Tine Kold Olesen, Fritz H Schröder","publishingOrg":"BJU international","publicationYear":2008,"doi":"10.1111/j.1464-410x.2008.08183.x","pubmedId":"19035858","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1111/j.1464-410x.2008.08183.x","sourceIdentityId":"95582271c5ffc3c1d153eeced5b28353","sourceStatus":"active","sourceContentHash":"513880d0869837caadfa136f0a4e62b970c562c25d60c7d8ec385129b73c7648","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:19035858","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"A","score":91,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":70,"replication":70,"studyDesign":91,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1111/j.1464-410X.2008.08183.x","locator":"https://pubmed.ncbi.nlm.nih.gov/19035858/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"513880d0869837caadfa136f0a4e62b970c562c25d60c7d8ec385129b73c7648","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"19035858","rawPayloadReference":"pubmed:19035858"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"7e39da8ba3345d31118b3ecc3b41fc80","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"Comparative efficacy of triptorelin pamoate and leuprolide acetate in men with advanced prostate cancer.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/12887472/","evidenceTier":"phase_1_2","summary":"To compare the efficacy of monthly administrations of the luteinizing hormone-releasing hormone agonists triptorelin pamoate and leuprolide acetate to induce and maintain castrate levels of serum testosterone in men with advanced prostate cancer.","authors":"C F Heyns, M-P Simonin, P Grosgurin, R Schall, H C Porchet, South African Triptorelin Study Group","publishingOrg":"BJU international","publicationYear":2003,"doi":"10.1046/j.1464-410x.2003.04308.x","pubmedId":"12887472","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1046/j.1464-410x.2003.04308.x","sourceIdentityId":"61028f3fec3b01837a4bd2725da1a7cf","sourceStatus":"active","sourceContentHash":"3c765d0a7074d35d859d60ce5a412965c3a780621d52f823fded9871e787a90b","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:12887472","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"B","score":80,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":85,"replication":70,"studyDesign":80,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1046/j.1464-410x.2003.04308.x","locator":"https://pubmed.ncbi.nlm.nih.gov/12887472/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"3c765d0a7074d35d859d60ce5a412965c3a780621d52f823fded9871e787a90b","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"12887472","rawPayloadReference":"pubmed:12887472"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"a346771972b5e9377ba990fd829af64c","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"Comparison of leuprolide acetate and triptorelin in assisted reproductive technology cycles: a prospective, randomized study.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/12477523/","evidenceTier":"phase_1_2","summary":"To compare the use of two depot GnRH-a, leuprolide and triptorelin, in long-suppression GnRH-a protocols.","authors":"Raoul Orvieto, Ram Kerner, Haim Krissi, Jacob Ashkenazi, Zion Ben Rafael, Itai Bar-Hava","publishingOrg":"Fertility and sterility","publicationYear":2002,"doi":"10.1016/s0015-0282(02)04262-0","pubmedId":"12477523","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1016/s0015-0282(02)04262-0","sourceIdentityId":"3e49e0ab8126ccd334386b6e043762e5","sourceStatus":"active","sourceContentHash":"be691a50a8ff5b3a575bd13a3017e3c61a5a70584ee455163632e77b1023d819","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:12477523","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"B","score":80,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":85,"replication":70,"studyDesign":80,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1016/s0015-0282(02)04262-0","locator":"https://pubmed.ncbi.nlm.nih.gov/12477523/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"be691a50a8ff5b3a575bd13a3017e3c61a5a70584ee455163632e77b1023d819","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"12477523","rawPayloadReference":"pubmed:12477523"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"6d2a1df5fe477f272ebfd070a9ae4c95","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/11580742/","evidenceTier":"phase_1_2","summary":"To determine whether length of pre-operative treatment with gonadotrophin-releasing hormone agonists (GnRHa) may have different effects on uterine shrinkage and intra-operative blood loss, 36 patients with symptomatic uterine fibroids awaiting myomectomy were randomly divided into two groups.","authors":"V M Jasonni, R D'Anna, A Mancuso, C Caruso, F Corrado, I Leonardi","publishingOrg":"Acta obstetricia et gynecologica Scandinavica","publicationYear":2001,"doi":"10.1034/j.1600-0412.2001.801014.x","pubmedId":"11580742","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1034/j.1600-0412.2001.801014.x","sourceIdentityId":"43069a42d69c59854fb51247af6cbcdc","sourceStatus":"active","sourceContentHash":"b486e69d6523ca9c5621738f22bbc0f61a4be62c9ad179ee1f5e035fa810b075","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:11580742","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"B","score":80,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":85,"replication":70,"studyDesign":80,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1034/j.1600-0412.2001.801014.x","locator":"https://pubmed.ncbi.nlm.nih.gov/11580742/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"b486e69d6523ca9c5621738f22bbc0f61a4be62c9ad179ee1f5e035fa810b075","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"11580742","rawPayloadReference":"pubmed:11580742"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"cc31639393d06d608b4784d8d25d75f2","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/9464714/","evidenceTier":"phase_1_2","summary":"To evaluate the efficacy and safety of a GnRH agonist, leuprolide acetate depot, alone and in combination with three hormonal add-back regimens in the management of endometriosis-associated pelvic pain.","authors":"M D Hornstein, E S Surrey, G W Weisberg, L A Casino","publishingOrg":"Obstetrics and gynecology","publicationYear":1998,"doi":"10.1016/s0029-7844(97)00620-0","pubmedId":"9464714","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1016/s0029-7844(97)00620-0","sourceIdentityId":"2504aff1ade443c63c531e77ced8b8ec","sourceStatus":"active","sourceContentHash":"290bf417e17dac785b691bf352f769b8b7088e340da0364d6f4d3f75a4c3a9a8","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:9464714","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"B","score":80,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":85,"replication":70,"studyDesign":80,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1016/s0029-7844(97)00620-0","locator":"https://pubmed.ncbi.nlm.nih.gov/9464714/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"290bf417e17dac785b691bf352f769b8b7088e340da0364d6f4d3f75a4c3a9a8","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"9464714","rawPayloadReference":"pubmed:9464714"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"c34a1e10df1665a592b6b4caadb798b6","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"Absence of a dose-response effect of leuprolide acetate on leiomyomata uteri size.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/8194611/","evidenceTier":"phase_1_2","summary":"To evaluate the effects of two different doses (3.75 mg versus 7.5 mg) of leuprolide acetate (LA, Lupron; Tap Pharmaceuticals, Deerfield, IL) on myoma size, blood loss during myomectomy, on magnetic resonance imaging (MRI) signal quality, and histopathologic changes in women requiring myomectomy.","authors":"R J Kiltz, J Rutgers, J Phillips, M L Murugesapillai, O A Kletzky","publishingOrg":"Fertility and sterility","publicationYear":1994,"doi":null,"pubmedId":"8194611","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"pmid:8194611","sourceIdentityId":"cdd839a8259902f13f86c23bcf6e2854","sourceStatus":"active","sourceContentHash":"e156a0b9a59a60f64372de1d3843d9758063baea6c4f1a00f529c5b208e39be4","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:8194611","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"B","score":80,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":85,"replication":70,"studyDesign":80,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":null,"locator":"https://pubmed.ncbi.nlm.nih.gov/8194611/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"e156a0b9a59a60f64372de1d3843d9758063baea6c4f1a00f529c5b208e39be4","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"8194611","rawPayloadReference":"pubmed:8194611"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"df0f274a6a54d688808288d0dd7d897b","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"Gonadotropin-releasing hormone agonist use before hysterectomy.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/8203435/","evidenceTier":"phase_1_2","summary":"Our purpose was to compare the effects of leuprolide acetate in patients with symptomatic uterine leiomyoma before hysterectomy.","authors":"T G Stovall, R L Summit, S A Washburn, F W Ling","publishingOrg":"American journal of obstetrics and gynecology","publicationYear":1994,"doi":null,"pubmedId":"8203435","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"pmid:8203435","sourceIdentityId":"b7275199a8f4357eaab82aba27437eb8","sourceStatus":"active","sourceContentHash":"8a57f34743f318dcf3b65c6e472e2164d3dd3868d3dd86ed0acf8f85297c2711","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:8203435","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"B","score":80,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":70,"replication":70,"studyDesign":80,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":null,"locator":"https://pubmed.ncbi.nlm.nih.gov/8203435/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"8a57f34743f318dcf3b65c6e472e2164d3dd3868d3dd86ed0acf8f85297c2711","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"8203435","rawPayloadReference":"pubmed:8203435"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"1a627c61634a2942ae27738ec89459a8","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"Role of leuprolide acetate depot in hysteroscopic surgery: a controlled study.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/8458448/","evidenceTier":"phase_1_2","summary":"To evaluate leuprolide acetate (LA) depot (Enantone Depot, Takeda, Italy) when administered preoperatively in hysteroscopic surgery.","authors":"A Perino, N Chianchiano, M Petronio, E Cittadini","publishingOrg":"Fertility and sterility","publicationYear":1993,"doi":"10.1016/s0015-0282(16)55790-2","pubmedId":"8458448","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1016/s0015-0282(16)55790-2","sourceIdentityId":"25b6c873e26cb23c3e6112276bca0757","sourceStatus":"active","sourceContentHash":"45b7d092c47da92b5021a2cda119c984324546b559557f9d13794246b5da707b","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:8458448","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"B","score":80,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":85,"replication":70,"studyDesign":80,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1016/s0015-0282(16)55790-2","locator":"https://pubmed.ncbi.nlm.nih.gov/8458448/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"45b7d092c47da92b5021a2cda119c984324546b559557f9d13794246b5da707b","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"8458448","rawPayloadReference":"pubmed:8458448"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"9fd47e6664a6ff980e7f4344ca18144a","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/2503724/","evidenceTier":"phase_1_2","summary":"To test the hypothesis that maximal androgen blockade improves the effectiveness of the treatment of prostatic cancer, we conducted a randomized, double-blind trial in patients with disseminated, previously untreated prostate cancer (stage D2).","authors":"E D Crawford, M A Eisenberger, D G McLeod, J T Spaulding, R Benson, F A Dorr, B A Blumenstein, M A Davis, P J Goodman","publishingOrg":"The New England journal of medicine","publicationYear":1989,"doi":"10.1056/nejm198908173210702","pubmedId":"2503724","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1056/nejm198908173210702","sourceIdentityId":"058b18e690f98374f3eddc8525103c41","sourceStatus":"active","sourceContentHash":"bcf71d1123864357302d58bed9692578037a6b3cea2e8b739d03ffe3d5bea340","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:2503724","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"B","score":80,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":85,"replication":70,"studyDesign":80,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1056/NEJM198908173210702","locator":"https://pubmed.ncbi.nlm.nih.gov/2503724/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"bcf71d1123864357302d58bed9692578037a6b3cea2e8b739d03ffe3d5bea340","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"2503724","rawPayloadReference":"pubmed:2503724"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"},{"id":"db1316120883fd119232bbdba0d66292","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","title":"Single-dose pharmacokinetics of leuprolide in humans following intravenous and subcutaneous administration.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/3083092/","evidenceTier":"phase_1_2","summary":"A group of six normal adult male volunteers was divided into two groups (I and II) who received bolus intravenous and subcutaneous 1-mg doses of leuprolide.","authors":"L T Sennello, R A Finley, S Y Chu, C Jagst, D Max, D E Rollins, K G Tolman","publishingOrg":"Journal of pharmaceutical sciences","publicationYear":1986,"doi":"10.1002/jps.2600750211","pubmedId":"3083092","jurisdiction":null,"dateAccessed":"2026-09-09T22:34:17.625Z","editorialNotes":"Identity and metadata verified against the NCBI PubMed record; evidence strength is provisional pending Owner review.","sourceType":"peer_reviewed_research","claimSupported":"Directly informs the Leuprolide evidence profile within the limits of its study design.","supportNature":"Direct or contextual support; no extrapolation beyond the source design.","qualification":"Publication identity verified; full-text risk-of-bias and applicability require governed review.","verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"wpf-automation-profile-corpus-v1","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1002/jps.2600750211","sourceIdentityId":"429ef4a6240a112aa387b520d1e005a3","sourceStatus":"active","sourceContentHash":"a71f057e5c4708cea048432ae4323d75011bcff4c6b5ecdcccdceabf5d0b7454","sourceVersion":1,"retrievedAt":"2026-09-09T22:34:17.625Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":"pubmed:3083092","evidenceLane":"human_interventional","extractionPayload":{"outcomes":"No claim-level outcome imported without full-text adjudication.","limitations":"Source identity and relevance verified; detailed risk-of-bias and applicability remain for profile-level Owner review.","studyDesign":"randomized or prospective clinical study","sourceStrength":{"grade":"B","score":80,"version":"WPF-ESR-1.0","dimensions":{"identity":100,"directness":85,"replication":70,"studyDesign":80,"regulatoryRelevance":60},"provisional":true},"populationOrModel":"See source abstract and full text; identity verified at PubMed."},"provenancePayload":{"doi":"10.1002/jps.2600750211","locator":"https://pubmed.ncbi.nlm.nih.gov/3083092/","provider":"pubmed","sourceRole":"published_literature","retrievedAt":"2026-09-09T21:45:00Z","rawPayloadHash":"a71f057e5c4708cea048432ae4323d75011bcff4c6b5ecdcccdceabf5d0b7454","sourceRoleBasis":"provider_authoritative_index","providerRecordId":"3083092","rawPayloadReference":"pubmed:3083092"},"validationGates":{"gates":[{"id":"G1","passed":true,"required":true,"reasonCodes":[]},{"id":"G2","passed":true,"required":true,"reasonCodes":[]},{"id":"G3","passed":true,"required":true,"reasonCodes":[]},{"id":"G4","passed":true,"required":true,"reasonCodes":[]},{"id":"G5","passed":true,"required":true,"reasonCodes":[]},{"id":"G6","passed":true,"required":true,"reasonCodes":[]},{"id":"G7","passed":true,"required":true,"reasonCodes":[]},{"id":"G8","passed":true,"required":true,"reasonCodes":[]}],"sourceRole":"published_literature","disposition":"promote_internal","reasonCodes":[],"catastrophic":false,"ownerAuthorized":false,"sourceRoleBasis":"provider_authoritative_index","citationSourceType":"peer_reviewed_research","admitsExactPublishedEvidence":true},"engineState":"promoted_internal","engineRunId":null,"createdAt":"2026-09-09T22:34:17.625Z","updatedAt":"2026-09-09T22:55:41.437Z"}],"regulatory":[{"id":"1082cc6a3edec1ea92683ce594c809eb","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","jurisdiction":"United States (FDA — LUPRON DEPOT)","status":"approved","approvedIndication":"LUPRON DEPOT leuprolide acetate is FDA-approved in product-specific depot formulations for palliative treatment of advanced prostate cancer and for other indications only as stated in the applicable current labeling.","rationale":"Authorization differs by application, strength, dosing interval, population, and indication. Current product labeling controls tumor-flare warnings, metabolic and cardiovascular risks, bone effects, interactions, contraindications, and administration.","sourceTitle":"FDA Drugs@FDA — LUPRON DEPOT NDA 019943","sourceUrl":"https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019943","dateChecked":"2026-09-09T22:35:39.247Z","reviewDueAt":"2026-12-08T22:35:39.247Z","enteredById":null,"reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","publicationStatus":"published","factualObservationId":null,"createdAt":"2026-09-09T22:35:39.247Z","updatedAt":"2026-09-09T22:55:41.464Z"},{"id":"b91f3ba0983591c6f3558a6dc418dbd9","peptideId":"53faaf54-4d86-409b-ad02-9244e78182d9","jurisdiction":"United States (FDA — LUPRON DEPOT-PED)","status":"approved","approvedIndication":"LUPRON DEPOT-PED is FDA-approved for treatment of pediatric patients with central precocious puberty under its age-, formulation-, dose-, and monitoring-specific labeling.","rationale":"This pediatric authorization is distinct from adult oncology and gynecologic products. The current label controls diagnosis, pubertal suppression monitoring, psychiatric and neurologic warnings, dosing interval, and administration.","sourceTitle":"FDA Drugs@FDA — LUPRON DEPOT-PED NDA 020263","sourceUrl":"https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020263","dateChecked":"2026-09-09T22:35:39.247Z","reviewDueAt":"2026-12-08T22:35:39.247Z","enteredById":null,"reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","publicationStatus":"published","factualObservationId":null,"createdAt":"2026-09-09T22:35:39.247Z","updatedAt":"2026-09-09T22:55:41.464Z"}],"claims":[],"correctionHistory":[],"boundaries":{"observationsAreEvidence":false,"completionIsPublicationApproval":false,"medicalAdvice":false}}